S K Kurdistani

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Enhancer dysfunction: how the main regulators of gene expression contribute to cancer
    Siavash K Kurdistani
    Department of Biological Chemistry and Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, David Geff en School of Medicine, University of California, Los Angeles, CA 90095, USA
    Genome Biol 13:156. 2012
  2. ncbi Histone modifications as markers of cancer prognosis: a cellular view
    S K Kurdistani
    Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, CA 90095 1737, USA
    Br J Cancer 97:1-5. 2007
  3. ncbi Global levels of histone modifications predict prognosis in different cancers
    David B Seligson
    Departments of Pathology and Laboratory Medicine, Human Genetics, David GeffenSchool of Medicine, University of California, Los Angeles, California 90095 1737, USA
    Am J Pathol 174:1619-28. 2009
  4. ncbi Histone modifications in cancer biology and prognosis
    Siavash K Kurdistani
    Department of Biological Chemistry and Pathology, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA
    Prog Drug Res 67:91-106. 2011
  5. ncbi Acetylation of yeast histone H4 lysine 16: a switch for protein interactions in heterochromatin and euchromatin
    C B Millar
    Department of Biological Chemistry, UCLA School of Medicine and the Molecular Biology Institute, Los Angeles, California 90095, USA
    Cold Spring Harb Symp Quant Biol 69:193-200. 2004

Collaborators

Detail Information

Publications5

  1. ncbi Enhancer dysfunction: how the main regulators of gene expression contribute to cancer
    Siavash K Kurdistani
    Department of Biological Chemistry and Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, David Geff en School of Medicine, University of California, Los Angeles, CA 90095, USA
    Genome Biol 13:156. 2012
    ..A genome-wide epigenetic analysis of enhancer elements in colon cancer has implicated distal gene regulatory DNA sequences in the establishment of an oncogenic transcriptional program...
  2. ncbi Histone modifications as markers of cancer prognosis: a cellular view
    S K Kurdistani
    Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, CA 90095 1737, USA
    Br J Cancer 97:1-5. 2007
    ..This novel cellular epigenetic heterogeneity is related to clinical outcome of cancer patients and may serve as a valuable marker of prognosis...
  3. ncbi Global levels of histone modifications predict prognosis in different cancers
    David B Seligson
    Departments of Pathology and Laboratory Medicine, Human Genetics, David GeffenSchool of Medicine, University of California, Los Angeles, California 90095 1737, USA
    Am J Pathol 174:1619-28. 2009
    ....
  4. ncbi Histone modifications in cancer biology and prognosis
    Siavash K Kurdistani
    Department of Biological Chemistry and Pathology, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA
    Prog Drug Res 67:91-106. 2011
    ..The challenge before us is to understand how global levels of histone modifications are established and maintained and what their mechanistic links are to the cancer clinical behavior...
  5. ncbi Acetylation of yeast histone H4 lysine 16: a switch for protein interactions in heterochromatin and euchromatin
    C B Millar
    Department of Biological Chemistry, UCLA School of Medicine and the Molecular Biology Institute, Los Angeles, California 90095, USA
    Cold Spring Harb Symp Quant Biol 69:193-200. 2004